Edit Entry | Edit CV

Jonathan D. Marotti, MD

Title(s)
Associate Professor of Pathology and Laboratory Medicine

Department(s)
Pathology and Laboratory Medicine

Education
Dartmouth Medical School, 2005
Anatomic and Clinical Pathology Residency, Beth Israel Deaconess Medical Center, 2005-2009
Breast Pathology Fellowship, Beth Israel Deaconess Medical Center, 2009-2010
Cytopathology Fellowship, Dartmouth-Hitchcock Medical Center, 2010-2011

Programs
Dartmouth Cancer Center

Academic Analytics
View Profile

Contact Information

Professional Interests

Breast pathology
Cytopathology

Selected Publications
 

Does ROSE matter? Evaluation of final diagnostic, PD-L1 immunohistochemistry, and molecular testing yields of CT-guided lung biopsies performed before and after the onset of the COVID-19 pandemic.
Jennings EB, Percarpio RB, Tafe LJ, Demidenko E, Levy J, Gutmann EJ, Marotti JD
J Am Soc Cytopathol. 2024 Jul-Aug;13(4):263-271. doi: 10.1016/j.jasc.2024.03.004. Epub 2024 Mar 29.
PMID: 38677893

Chondrolipoma of the Breast: A Myofibroblastoma Variant or a Distinct Lesion?
Workman AA, Green DC, Hughes EG, Shah PS, Cloutier JM, Marotti JD
Int J Surg Pathol. 2024 Feb 14;:10668969241231975. doi: 10.1177/10668969241231975. Epub 2024 Feb 14.
PMID: 38356303

Guar beans in a peritoneal fluid sample.
Gutmann EJ, Marotti JD
Cytopathology. 2024 May;35(3):425-426. doi: 10.1111/cyt.13351. Epub 2023 Dec 21.
PMID: 38126698

Sixteen-Year Institutional Review of Magnetic Resonance Imaging-Guided Breast Biopsies: Trends in Histologic Diagnoses With Radiologic Correlation.
Motanagh SA, Dwan D, Azizgolshani N, E Muller K, diFlorio-Alexander RM, Marotti JD
Breast Cancer (Auckl). 2023;17:11782234231215193. doi: 10.1177/11782234231215193. Epub 2023 Nov 28.
PMID: 38034324

Use of molecular testing results to analyze the overuse of atypia of undetermined significance in thyroid cytology.
Martinez Coconubo D, Levy JJ, Kerr DA, Vaickus LJ, Vidis L, Glass RE, Gutmann EJ, Marotti JD, Liu X
J Am Soc Cytopathol. 2023 Nov-Dec;12(6):451-460. doi: 10.1016/j.jasc.2023.09.002. Epub 2023 Sep 7.
PMID: 37775434

Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer.
Traphagen NA, Schwartz GN, Tau S, Roberts AM, Jiang A, Hosford SR, Marotti JD, Goen AE, Romo BA, Johnson AL, Duffy EK, Demidenko E, Heverly P, Mosesson Y, Soucy SM, Kolling F, Miller TW
Clin Cancer Res. 2023 Sep 15;29(18):3717-3728. doi: 10.1158/1078-0432.CCR-23-0488.
PMID: 37439680

Large-scale validation study of an improved semiautonomous urine cytology assessment tool: AutoParis-X.
Levy JJ, Chan N, Marotti JD, Kerr DA, Gutmann EJ, Glass RE, Dodge CP, Suriawinata AA, Christensen BC, Liu X, Vaickus LJ
Cancer Cytopathol. 2023 Oct;131(10):637-654. doi: 10.1002/cncy.22732. Epub 2023 Jun 28.
PMID: 37377320

Examining longitudinal markers of bladder cancer recurrence through a semiautonomous machine learning system for quantifying specimen atypia from urine cytology.
Levy JJ, Chan N, Marotti JD, Rodrigues NJ, Ismail AAO, Kerr DA, Gutmann EJ, Glass RE, Dodge CP, Suriawinata AA, Christensen BC, Liu X, Vaickus LJ
Cancer Cytopathol. 2023 Sep;131(9):561-573. doi: 10.1002/cncy.22725. Epub 2023 Jun 26.
PMID: 37358142

Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer.
Schwartz GN, Kaufman PA, Giridhar KV, Marotti JD, Chamberlin MD, Arrick BA, Makari-Judson G, Goetz MP, Soucy SM, Kolling F, Demidenko E, Miller TW
Clin Cancer Res. 2023 Aug 1;29(15):2767-2773. doi: 10.1158/1078-0432.CCR-23-0112.
PMID: 37260292

Periductal Stromal Tumor of the Breast with a TERT Promoter Mutation: First Case Report with Comprehensive Molecular Analysis.
Anderson B, Marotti JD, Lefferts JA, Muller KE
Int J Surg Pathol. 2023 Dec;31(8):1626-1631. doi: 10.1177/10668969231157306. Epub 2023 Feb 23.
PMID: 36823780

View more publications on PubMed